The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Bruker Corp’s stock clocked out at $49.03, down -0.61% from its previous closing price of $49.33. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 2.52 million shares were traded. BRKR stock price reached its highest trading level at $49.33 during the session, while it also had its lowest trading level at $48.0.
Ratios:
To gain a deeper understanding of BRKR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.82.
Upgrades & Downgrades
In the most recent recommendation for this company, Rothschild & Co Redburn on November 20, 2025, initiated with a Buy rating and assigned the stock a target price of $60.
On May 22, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $40.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $72.Guggenheim initiated its Buy rating on December 19, 2024, with a $72 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 06 ’25 when ORNELL JOHN A sold 6,233 shares for $39.00 per share. The transaction valued at 243,087 led to the insider holds 35,212 shares of the business.
JOHN ORNELL bought 6,233 shares of BRKR for $243,121 on Nov 06 ’25. On Sep 12 ’25, another insider, Friend Cynthia M, who serves as the Director of the company, sold 3,535 shares for $32.25 each. As a result, the insider received 113,990 and left with 18,016 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 7449674752 and an Enterprise Value of 9264574464. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.17 while its Price-to-Book (P/B) ratio in mrq is 3.05. Its current Enterprise Value per Revenue stands at 2.694 whereas that against EBITDA is 15.837.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.14, which has changed by -0.15392578 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $64.64, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 28.08%, while the 200-Day Moving Average is calculated to be 24.75%.
Shares Statistics:
It appears that BRKR traded 3.75M shares on average per day over the past three months and 2580230 shares per day over the past ten days. A total of 151.39M shares are outstanding, with a floating share count of 103.20M. Insiders hold about 32.13% of the company’s shares, while institutions hold 88.69% stake in the company. Shares short for BRKR as of 1763078400 were 13424506 with a Short Ratio of 3.58, compared to 1760486400 on 13347504. Therefore, it implies a Short% of Shares Outstanding of 13424506 and a Short% of Float of 19.02.
Dividends & Splits
With its trailing 12-month dividend rate of 0.2, BRKR has a forward annual dividend rate of 0.20. Against a Trailing Annual Dividend Yield of 0.004054328. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
As of right now, 12.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.42, with high estimates of $0.61 and low estimates of $0.26.
Analysts are recommending an EPS of between $1.9 and $1.86 for the fiscal current year, implying an average EPS of $1.88. EPS for the following year is $2.15, with 14.0 analysts recommending between $2.44 and $2.0.
Revenue Estimates
In. The current quarter, 11 analysts expect revenue to total $958.8M. It ranges from a high estimate of $966.5M to a low estimate of $952.51M. As of. The current estimate, Bruker Corp’s year-ago sales were $979.6MFor the next quarter, 11 analysts are estimating revenue of $801.63M. There is a high estimate of $828.43M for the next quarter, whereas the lowest estimate is $766.8M.
A total of 12 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.43B, while the lowest revenue estimate was $3.41B, resulting in an average revenue estimate of $3.42B. In the same quarter a year ago, actual revenue was $3.37BBased on 12 analysts’ estimates, the company’s revenue will be $3.48B in the next fiscal year. The high estimate is $3.55B and the low estimate is $3.43B.
